Published 5 hours ago • loading... • Updated 5 hours ago

An ‘Ozempic baby boom’? The GLP-1 pregnancy plot twist : Short Wave

Summary by Npr

Open the article to view the coverage from npr

1 Articles

npr

Lean Left

An ‘Ozempic baby boom’? The GLP-1 pregnancy plot twist : Short Wave

Open the article to view the coverage from npr

5 hours ago·Washington, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left1Leaning Right0Center0Last Updated5 hours agoBias Distribution

100% Left

Bias Distribution

100% of the sources lean Left

100% Left

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

npr broke the news in Washington, United States 5 hours ago on Monday, November 9, 2026.

Sources are mostly out of (0)

An ‘Ozempic baby boom’? The GLP-1 pregnancy plot twist : Short Wave

1 Articles

1 Articles

An ‘Ozempic baby boom’? The GLP-1 pregnancy plot twist : Short Wave

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

AbbVie reports improved facial satisfaction among weight-loss drug users (ABBV:NYSE)

Experimental Weight-Loss Drug Eases Painful Knee Osteoarthritis in Two Clinical Trials

‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s

Novo Post Hoc Analysis Finds Wegovy® 2.4 Mg Was Associated with Improvements in Liver Markers in Adults with MASH with Liver Scarring and a BMI Less than 27 Kg/m2, Presented at The Liver Meeting® (AASLD) 2026

Alternatives to Wegovy & Ozempic: What Can Orforglipron and Retatrutide Do?

Rubio Says Trump’s War Against Iran Not ‘Necessarily Popular’ but Needed to Stop a Nuclear Threat – WTOP News

Similar News Topics

Similar News Topics

More stories like this

AbbVie reports improved facial satisfaction among weight-loss drug users (ABBV:NYSE)

Experimental Weight-Loss Drug Eases Painful Knee Osteoarthritis in Two Clinical Trials

‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s

Novo Post Hoc Analysis Finds Wegovy® 2.4 Mg Was Associated with Improvements in Liver Markers in Adults with MASH with Liver Scarring and a BMI Less than 27 Kg/m2, Presented at The Liver Meeting® (AASLD) 2026

Alternatives to Wegovy & Ozempic: What Can Orforglipron and Retatrutide Do?

Rubio Says Trump’s War Against Iran Not ‘Necessarily Popular’ but Needed to Stop a Nuclear Threat – WTOP News

An ‘Ozempic baby boom’? The GLP-1 pregnancy plot twist : Short Wave

1 Articles

1 Articles

An ‘Ozempic baby boom’? The GLP-1 pregnancy plot twist : Short Wave

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

AbbVie reports improved facial satisfaction among weight-loss drug users (ABBV:NYSE)

Experimental Weight-Loss Drug Eases Painful Knee Osteoarthritis in Two Clinical Trials

‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s

Novo Post Hoc Analysis Finds Wegovy® 2.4 Mg Was Associated with Improvements in Liver Markers in Adults with MASH with Liver Scarring and a BMI Less than 27 Kg/m2, Presented at The Liver Meeting® (AASLD) 2026

Alternatives to Wegovy & Ozempic: What Can Orforglipron and Retatrutide Do?

Rubio Says Trump’s War Against Iran Not ‘Necessarily Popular’ but Needed to Stop a Nuclear Threat – WTOP News

Similar News Topics

Similar News Topics

More stories like this

AbbVie reports improved facial satisfaction among weight-loss drug users (ABBV:NYSE)

Experimental Weight-Loss Drug Eases Painful Knee Osteoarthritis in Two Clinical Trials

‘Feeling really weak and shaky’: Experts warn of malnutrition risks on GLP-1s

Novo Post Hoc Analysis Finds Wegovy® 2.4 Mg Was Associated with Improvements in Liver Markers in Adults with MASH with Liver Scarring and a BMI Less than 27 Kg/m2, Presented at The Liver Meeting® (AASLD) 2026

Alternatives to Wegovy & Ozempic: What Can Orforglipron and Retatrutide Do?

Rubio Says Trump’s War Against Iran Not ‘Necessarily Popular’ but Needed to Stop a Nuclear Threat – WTOP News

Bias Distribution

Factuality